184 related articles for article (PubMed ID: 33420542)
1. Validation of systemic parameters for the diagnosis of ocular sarcoidosis.
Suzuki K; Namba K; Mizuuchi K; Iwata D; Ito T; Hase K; Kitaichi N; Ishida S
Jpn J Ophthalmol; 2021 Mar; 65(2):191-198. PubMed ID: 33420542
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
Ishihara M; Meguro A; Ishido M; Takeuchi M; Shibuya E; Mizuki N
Clin Ophthalmol; 2020; 14():2311-2317. PubMed ID: 32848359
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
[TBL] [Abstract][Full Text] [Related]
5. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).
Herbort CP; Rao NA; Mochizuki M;
Ocul Immunol Inflamm; 2009; 17(3):160-9. PubMed ID: 19585358
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
7. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy.
Chen W; Zhang Q; Li M; Huang G; Guo L; Chen Z; Ding Q; Gu Y
Clin Chim Acta; 2023 May; 545():117372. PubMed ID: 37127231
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing Features of Ocular Sarcoidosis in an International Cohort of Uveitis Patients.
Acharya NR; Browne EN; Rao N; Mochizuki M;
Ophthalmology; 2018 Jan; 125(1):119-126. PubMed ID: 28823384
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.
Gundlach E; Hoffmann MM; Prasse A; Heinzelmann S; Ness T
PLoS One; 2016; 11(1):e0147258. PubMed ID: 26799486
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of revised diagnosis criteria for sarcoidosis].
Kiyotake R; Okinami S; Soma M; Hirata A; Ishigooka H; Kita M; Inada K
Nippon Ganka Gakkai Zasshi; 2010 Aug; 114(8):678-82. PubMed ID: 20803987
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
Keijsers RG; Verzijlbergen FJ; Oyen WJ; van den Bosch JM; Ruven HJ; van Velzen-Blad H; Grutters JC
Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1131-7. PubMed ID: 19259660
[TBL] [Abstract][Full Text] [Related]
12. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of serum markers in pulmonary sarcoidosis.
Miyoshi S; Hamada H; Kadowaki T; Hamaguchi N; Ito R; Irifune K; Higaki J
Chest; 2010 Jun; 137(6):1391-7. PubMed ID: 20081103
[TBL] [Abstract][Full Text] [Related]
14. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
[TBL] [Abstract][Full Text] [Related]
15. Findings and Graduation of Sarcoidosis-Related Uveitis: A Single-Center Study.
Zur Bonsen LS; Pohlmann D; Rübsam A; Pleyer U
Cells; 2021 Dec; 11(1):. PubMed ID: 35011651
[TBL] [Abstract][Full Text] [Related]
16. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.
Kitaichi N; Ariga T; Kase S; Yoshida K; Namba K; Ohno S
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):433-7. PubMed ID: 16133026
[TBL] [Abstract][Full Text] [Related]
18. Utility of Screening Investigations for Systemic Sarcoidosis in Undifferentiated Uveitis.
Niederer RL; Sims JL
Am J Ophthalmol; 2019 Oct; 206():149-153. PubMed ID: 31009595
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 mRNA Vaccine-Associated Uveitis Leading to Diagnosis of Sarcoidosis: Case Report and Review of Literature.
Matsuo T; Honda H; Tanaka T; Uraguchi K; Kawahara M; Hagiya H
J Investig Med High Impact Case Rep; 2022; 10():23247096221086450. PubMed ID: 35313760
[TBL] [Abstract][Full Text] [Related]
20. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
